Table 3 Number of inter/ intra-chromosomal fusions by chromosome
From: Prognostic value of structural variants in early breast cancer patients
Chromosome | All fusions | Known fusions | ||
|---|---|---|---|---|
Inter-chromosomal | Intra-chromosomal | Inter-chromosomal | Intra-chromosomal | |
chr1 | 135 (26.3%) | 378 (73.7%) | 1 (1.3%) | 76 (98.7%) |
chr2 | 85 (33.3%) | 170 (66.7%) | 1 (2.7%) | 36 (97.3%) |
chr3 | 86 (31.6%) | 186 (68.4%) | 0 (0%) | 56 (100%) |
chr4 | 65 (40.4%) | 96 (59.6%) | 0 (0%) | 18 (100%) |
chr5 | 90 (51.7%) | 84 (48.3%) | 0 (0%) | 18 (100%) |
chr6 | 94 (35.9%) | 168 (64.1%) | 0 (0%) | 34 (100%) |
chr7 | 77 (38.3%) | 124 (61.7%) | 0 (0%) | 42 (100%) |
chr8 | 100 (35.7%) | 180 (64.3%) | 0 (0%) | 58 (100%) |
chr9 | 67 (43.2%) | 88 (56.8%) | 0 (0%) | 22 (100%) |
chr10 | 77 (41.6%) | 108 (58.4%) | 1 (4.3%) | 22 (95.7%) |
chr11 | 70 (24.5%) | 216 (75.5%) | 0 (0%) | 48 (100%) |
chr12 | 86 (44.8%) | 106 (55.2%) | 0 (0%) | 40 (100%) |
chr13 | 40 (44.4%) | 50 (55.6%) | 0 (0%) | 12 (100%) |
chr14 | 34 (36.2%) | 60 (63.8%) | 0 (0%) | 24 (100%) |
chr15 | 56 (39.4%) | 86 (60.6%) | 0 (0%) | 24 (100%) |
chr16 | 58 (29.6%) | 138 (70.4%) | 0 (0%) | 26 (100%) |
chr17 | 154 (23.3%) | 508 (76.7%) | 1 (1.3%) | 78 (98.7%) |
chr18 | 32 (47.1%) | 36 (52.9%) | 1 (20%) | 4 (80%) |
chr19 | 63 (26.4%) | 176 (73.6%) | 1 (4%) | 24 (96%) |
chr20 | 70 (39.8%) | 106 (60.2%) | 0 (0%) | 30 (100%) |
chr21 | 38 (47.5%) | 42 (52.5%) | 0 (0%) | 6 (100%) |
chr22 | 42 (35.6%) | 76 (64.4%) | 0 (0%) | 20 (100%) |
chrX | 43 (55.8%) | 34 (44.2%) | 0 (0%) | 6 (100%) |
chrY | 0 (100%) | 0 (0%) | 0 (100%) | 0 (0%) |
